BUZZ-U.S. STOCKS ON THE MOVE-Apple, Trina, NephroGenex, Atara
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street was little changed on Monday, two days ahead of an expected U.S. interest rate hike, as crude oil prices hovered near 11-year lows. The Dow Jones industrial average was down 0.31 percent at 17,211.56, the S&P 500 was down 0.32 percent at 2,005.92 and the Nasdaq Composite was down 0.31 percent at 4,918.002.
** TRINA SOLAR LTD, $10.61, +11.10 pct
The Chinese solar panel maker said on Monday it received a preliminary proposal from its chief executive and Shanghai Xingsheng Equity Investment & Management Co to take the company private.
** ATARA BIOTHERAPEUTICS INC, $23.3, -29.82 pct
The drug developer said it would stop developing its kidney drug after the treatment failed to meet the main goal of a mid-stage study.
** APPLE INC, $110.87, -2.04 pct
Barclays and Morgan Stanley cut their price targets on the IPhone maker's stock. Morgan Stanley analysts in a note on Sunday said IPhone unit sales are expected to fall about 6 percent in FY16 as higher prices in markets outside the Americas, excluding China, and maturing smartphone penetration in developed markets weigh on upgrades and new user growth. Continued...